IPO Premiums
IPO calendar
HNListed

Himalaya Nutravedics India Limited

Bookbuilding IPO · BSE

Price band
₹100 - ₹106
Lot size
1,200 shares
Issue amount
₹26.49 cr
Total subscription
2.33×
Current price₹118.95
Listing price ₹118
Watch live price ↗
Opens
22 Sept 2026
Closes
24 Sept 2026
Allotment
25 Sept 2026
Listing
29 Sept 2026

Offer at a glance

Issue overview

Issue size
24,99,600 shares
Face value
₹10 per share
Minimum investment
₹1,20,000
Fresh issue
₹26.49 cr
Offer for sale
₹0 cr
Registrar
Kfin Technologies Limited
Listing exchange
BSE
Maximum investment
₹1,27,200
Issue type
Bookbuilding IPO
Shares before issue
63,06,720
Shares after issue
88,06,720

Lot sizes

CategoryLotsSharesAmount
RETAIL22,400₹2,54,400
sHNI33,600₹3,81,600
bHNI89,600₹10,17,600

Share reservation

Anchor28.42%
QIB18.96%
HNI14.26%
RETAIL33.32%
Market Maker5.04%

Subscription & GMP

Subscription by category

Total subscribed2.33×

Reported 24 Sept 2026

QIB1×
NIB3.58×
RETAIL2.56×
HNIs(10L+)3.84×
HNIs(2-10L)3.04×

GMP history

00.5131 Mar: ₹016 Sept: ₹017 Sept: ₹019 Sept: ₹021 Sept: ₹022 Sept: ₹023 Sept: ₹024 Sept: ₹019 Oct: ₹020 Oct: ₹021 Oct: ₹022 Oct: ₹023 Oct: ₹0
31 Mar₹023 Oct

Day-wise demand

22 Sept0.11×
23 Sept0.44×
24 Sept2.33×

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL347889
HNIs(10L +)6647
HNIs (2-10L)3393

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs5.025.02
RETAIL8.8322.62
NIB3.7812.9
HNIs 2+1.263.83
HNIs 10+2.529.68
HNIs3.7813.51

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
0204060Mar-24 · Revenue: 14.43Mar-24 · Profit after tax: 0.43Mar-24Mar-25 · Revenue: 21Mar-25 · Profit after tax: 2.23Mar-25Mar-26 · Revenue: 43.12Mar-26 · Profit after tax: 7.39Mar-26
RevenueProfit after tax

Key performance indicators

MetricMar-26Mar-25Mar-24
EPS18.3324.815.13
ROE000
ROCE000
RONW45.1233.0831.77
PRE IPO(PE)9.0400
POST IPO(PE)12.6300

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Himalaya Nutravedics India Limited9.04010.0026.7045.1212.05
Jeena Sikho Lifecare Limited28.7502.0037.6027.6717.84
Sandu Pharmaceuti cals Limite20.62010.0045.212.531.83

Company information

Company profile

Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India, along with offering third-party contract manufacturing services for other companies in this space. The company has a diversified product portfolio comprising classical Ayurvedic formulations based on traditional texts, proprietary Ayurvedic products, and nutraceutical supplements, available in various dosage forms such as soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils. It operates on a hybrid business model that balances its own branded products with contract manufacturing, supported by an integrated in-house manufacturing facility located in Hyderabad, Telangana. As of September 2025, its products are distributed across multiple states including Telangana, Andhra Pradesh, Kerala, Gujarat, and Uttar Pradesh, with offerings catering to a wide range of wellness segments such as digestive health, immunity, metabolic health, joint care, reproductive health, respiratory wellness, pain management, and overall well-being, aligned with regulatory standards.

Strengths

  • Integrated Multi-Dosage Manufacturing: The company can manufacture different dosage forms, including capsules, tablets, oils, liquid orals and powders. This enables it to serve varied product needs across multiple therapeutic categories.
  • Strong Doctor Acceptance: The company promotes its branded products through healthcare practitioners, with product acceptance driven by performance rather than mass advertising. This supports its established branded product portfolio.
  • Long-Standing Relationships: Himalaya Nutravedics has built lasting relationships with its suppliers and customers. These relationships help support smooth procurement and sales operations.

Risk factors

  • Dependence on Ayurvedic Products: Ayurvedic products contributed 94.57%, 92.09% and 79.27% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. A decline in demand for these products could negatively affect the company’s business and financial performance.
  • Customer Concentration: The top 10 customers contributed 81.24%, 86.97% and 84.19% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. Losing key customers or facing lower or delayed orders could impact revenue, financial condition and cash flows.
  • Supplier Concentration: The company has historically sourced a significant share of its requirements from its top 10 suppliers. Any disruption in these supplier relationships could affect the availability of raw materials and other essential supplies.

Promoters

Rohit Asawa

Divya Asawa

Chanda Asawa

Rama Raju

Registrar & documents

Lead manager

Nirbhay Capital Services Private Limited

Registered office

Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal Hyderabad, Telangana, 500051

+91-9063498493

[email protected]Company website ↗

Frequently Asked Questions

What is Himalaya Nutravedics India IPO GMP today?

Currently, Himalaya Nutravedics India IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹106. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Himalaya Nutravedics India IPO?

The minimum bid lot size for Himalaya Nutravedics India IPO is 1,200 shares. At the cut-off price of ₹106 per share, retail investors need a minimum application amount of ₹1,27,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Himalaya Nutravedics India IPO allotment status be announced?

The allotment status for Himalaya Nutravedics India IPO is scheduled to be finalized on 25 Sept 2026. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Himalaya Nutravedics India IPO allotment status online by PAN?

To check Himalaya Nutravedics India IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Himalaya Nutravedics India Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Himalaya Nutravedics India IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums